Gachon University Gil Medical Center

Incheon, Seoul 21565

1 studies enrolling now · 2 studies all time

What they study most

Complete Response, Epithelial Ovarian Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Newly Diagnosed, Ovarian Cancer, Partial Response, Primary Peritoneal, Primary Peritoneal Cancer

Studies at this site

• Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer — Recruiting now
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling